Skip to content

Ultrasound-guided Selective Blockade of the Saphenous and Obturator Nerves Following Total Knee Arthroplasty

Selective Blocks for Total Knee Arthroplasty

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02465827
Enrollment
75
Registered
2015-06-09
Start date
2014-01-31
Completion date
2015-03-31
Last updated
2015-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthroplasty, Total

Brief summary

The investigators aimed to evaluate the efficacy of selective low volume ultrasound-guided blockades of the saphenous and obturator nerves on dynamic and rest pain 24-hours post-operatively for patients undergoing unilateral primary total knee arthroplasty.

Detailed description

A femoral nerve block is the recommended strategy in many surgical centers to supplement multimodal analgesic regime following total knee arthroplasty (TKA) (i.e. both for spinal and general anesthesia). However, a femoral nerve block will often result in quadriceps paralysis, and this will increase the risk for the patient to fall as long as the femoral block have effect. Thus, the search for sensory nerve blocks to stop pain after TKA is a very interesting topic. The saphenous nerve is a purely sensory nerve, and the posterior branch of the obturator nerve is a mixed nerve, where the motor component only affects part of the adductor major muscle.

Interventions

Ultrasound guided nerve blocks of the saphenous and obturator nerve, posterior branch with ropivacaine 0.75% for both nerve branches

DRUGnerve block with ropivacaine and with saline

nerve blocks of the saphenous nerve with ropivacaine 0.75% and obturator nerve, posterior branch with saline

DRUGnerve block with saline

Ultrasound guided nerve blocks of the saphenous and obturator nerve, posterior branch with saline for both nerve branches

Sponsors

Bispebjerg Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. American Society of Anesthesiologists' physical classification I-III 2. Age ≥ 18 years undergoing primary unilateral total knee arthroplasty

Exclusion criteria

1. Inability to cooperate 2. Inability to speak and understand Danish 3. Allergy to any drugs used in the study 4. Drug or alcohol abuse 5. Pregnancy or nursing 6. Opioid abusers

Design outcomes

Primary

MeasureTime frameDescription
Dynamic pain (pain upon movement) quantified as area-under-the-curve (AUC) 24-hours post-operatively24 hoursNRS 0-10

Secondary

MeasureTime frameDescription
Total opioid consumption24 hoursmg
Nausea and vomiting24 hoursNRS 0-10
Pain at rest quantified as area-under-the-curve (AUC) 24-hours post-operatively24 hoursNRS 0-10
Length of stay in recovery and hospital72 hourshours
Number of clinical complications72 hourstotal number
Time to first mobilization24 hourshours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026